THC Is an Ingredient, Where Pharma, MSOs & Hemp Collide, ft. Zach Edge episode artwork

EPISODE · Sep 11, 2025 · 43 MIN

THC Is an Ingredient, Where Pharma, MSOs & Hemp Collide, ft. Zach Edge

from The Dime · host Zach Edge, Kellan Finney, Bryan Fields

THC is an ingredient.Cannabinoids will be treated like standardized inputs across pharma, licensed cannabis, and hemp—and the future winners are hedging until there’s clarity.What got you here won’t get you there. The next phase needs a new playbook: ops tweaks aren’t enough; strategy has to change.Near term, expect Schedule III to unlock e-pharmacy distribution and centralized GMP manufacturing, while tobacco pushes device rules, alcohol shapes low-dose beverage norms, and hemp keeps expanding.This chaotic industry is about to get even crazier.This week we sit down with Zach Edge to discussTHC as a moleculeIntersection of pharma, hemp, and licensed cannabis:Schedule III breakdown: e-pharmacies, centralized GMP Chapters00:00 Introduction to Zach Edge and His Journey03:11 The Changing Landscape of THC Commercialization07:45 Hedge Strategies in Cannabis and Hemp14:28 Regulatory Challenges and Future Outlook20:02 The Role of Science in Cannabinoid Production36:11 Innovations in Cannabinoid Purification45:20 Final Thoughts and Future QuestionsSummaryIn this episode, Bryan Fields and Kellen Finney engage with Zach Edge, a seasoned expert in the cannabis and hemp industries. Zach shares his journey into the cannabis space, highlighting the evolution of THC commercialization and the impact of regulation on the industry. He discusses the importance of a hedge strategy for businesses operating in multiple verticals, the challenges posed by varying state regulations, and the role of science in cannabinoid production and purification. The conversation also touches on the future of the industry, including potential growth in the hemp sector and the need for regulatory clarity.Guest Linkshttps://www.linkedin.com/in/zach-edge/https://www.zachedge.com/Our LinksBryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

THC is an ingredient.Cannabinoids will be treated like standardized inputs across pharma, licensed cannabis, and hemp—and the future winners are hedging until there’s clarity. What got you here won’t get you there. The next phase needs a new playbook: ops tweaks aren’t enough; strategy has to change. Near term, expect Schedule III to unlock e-pharmacy distribution and centralized GMP manufacturing, while tobacco pushes device rules, alcohol shapes low-dose beverage norms, and hemp keeps expanding. This chaotic industry is about to get even crazier. This week we sit down with Zach Edge to discuss THC as a molecule Intersection of pharma, hemp, and licensed cannabis: Schedule III breakdown: e-pharmacies, centralized GMP Chapters 00:00 Introduction to Zach Edge and His Journey 03:11 The Changing Landscape of THC Commercialization 07:45 Hedge Strategies in Cannabis and Hemp 14:28 Regulatory Challenges and Future Outlook 20:02 The Role of Science in Cannabinoid Production 36:11 Innovations in Cannabinoid Purification 45:20 Final Thoughts and Future Questions Summary In this episode, Bryan Fields and Kellen Finney engage with Zach Edge, a seasoned expert in the cannabis and hemp industries. Zach shares his journey into the cannabis space, highlighting the evolution of THC commercialization and the impact of regulation on the industry. He discusses the importance of a hedge strategy for businesses operating in multiple verticals, the challenges posed by varying state regulations, and the role of science in cannabinoid production and purification. The conversation also touches on the future of the industry, including potential growth in the hemp sector and the need for regulatory clarity. Guest Links https://www.linkedin.com/in/zach-edge/ https://www.zachedge.com/ Our Links Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube:  The Dime 📸 Instagram:  The Dime https://www.newton-insights.com/

NOW PLAYING

THC Is an Ingredient, Where Pharma, MSOs & Hemp Collide, ft. Zach Edge

0:00 43:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Dime?

This episode is 43 minutes long.

When was this The Dime episode published?

This episode was published on September 11, 2025.

What is this episode about?

THC is an ingredient.Cannabinoids will be treated like standardized inputs across pharma, licensed cannabis, and hemp—and the future winners are hedging until there’s clarity.What got you here won’t get you there. The next phase needs a new...

Can I download this The Dime episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!